TrialJapanese journal of clinical oncology2024

A single arm Phase I/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424/OLCSG1402: CARNAVAL).

Naoyuki Nogami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.